GlassScriptPhysician profile
Jeffrey P Lawrence
NPI 1760473987
$3,000.25
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,161 · 2020: $233 · 2021: $147 · 2022: $439 · 2024: $20.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,126.80 | 2019-2022 | |
| Conformis, INC. | $214.68 | 2019-2020 | |
| Pacira Therapeutics, INC. | $131.92 | 2019-2021 | |
| Medacta USA, INC. | $70.40 | 2021 | |
| Horizon Therapeutics Plc | $61.49 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $53.54 | 2022 | |
| Orthofix Medical, INC. | $51.52 | 2019-2022 | |
| Depuy Synthes Sales INC. | $41.49 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $36.51 | 2019-2022 | |
| Smith+Nephew, INC. | $31.94 | 2019 | |
| Davol INC. | $31.89 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $27.18 | 2022 | |
| Orthogenrx INC. | $23.69 | 2019 | |
| Protega Pharmaceutials INC | $22.79 | 2022 | |
| Djo, LLC | $20.20 | 2024 | Cmf |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $17.41 | 2021 | |
| Radius Health, INC. | $16.69 | 2021 | |
| Endo Pharmaceuticals INC. | $13.46 | 2022 | |
| Trice Medical, INC. | $6.65 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,423,216.02 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.